27-hydroxycholesterol has been researched along with Endometrial Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collins, F; Cousins, FL; Esnal Zufiaurre, A; Gibson, DA; Saunders, PTK | 1 |
| Juberiya, AM; Sreeja, S; Vini, R | 1 |
2 other study(ies) available for 27-hydroxycholesterol and Endometrial Neoplasms
| Article | Year |
|---|---|
The impact of 27-hydroxycholesterol on endometrial cancer proliferation.
Topics: Adenocarcinoma; Benzoates; Benzylamines; Cell Proliferation; Endometrial Neoplasms; Endometrium; Female; Humans; Hydroxycholesterols; Hysterectomy | 2018 |
Evidence of pomegranate methanolic extract in antagonizing the endogenous SERM, 27-hydroxycholesterol.
Topics: Animals; Breast Neoplasms; Endometrial Neoplasms; Estrogen Receptor alpha; Female; Humans; Hydroxycholesterols; Lythraceae; MCF-7 Cells; Mice; Obesity; Ovarian Neoplasms; Plant Extracts; Uterine Cervical Neoplasms | 2016 |